40
Views
4
CrossRef citations to date
0
Altmetric
Research Article

COX-1, COX-2: So What?: EDITORIAL REVIEW

Pages 6-9 | Published online: 12 Jul 2009
 

Abstract

The discovery of the second isoform of cycloxygenase has led to a rapid expansion in basic science, pharmacology and clinical data. With the completion of phase III studies of the new COX-2 specific inhibitors this review examines some of the implications of the new data.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.